{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:44:47Z","timestamp":1761630287985,"version":"build-2065373602"},"reference-count":32,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2002,6,1]],"date-time":"2002-06-01T00:00:00Z","timestamp":1022889600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2002,6,1]],"date-time":"2002-06-01T00:00:00Z","timestamp":1022889600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,10]],"date-time":"2022-12-10T00:00:00Z","timestamp":1670630400000},"content-version":"vor","delay-in-days":7497,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2002,6]]},"DOI":"10.1034\/j.1600-6143.2002.20612.x","type":"journal-article","created":{"date-parts":[[2003,3,10]],"date-time":"2003-03-10T20:37:57Z","timestamp":1047328677000},"page":"568-573","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Limited Dose Monoclonal IL\u20102R Antibody Induction Protocol after Primary Kidney Transplantation"],"prefix":"10.1016","volume":"2","author":[{"given":"Nasimul","family":"Ahsan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Holman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark V.","family":"Jarowenko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad S.","family":"Razzaque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harold C.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3 Part 2","key":"10.1034\/j.1600-6143.2002.20612.x_bib1","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/j.1399-0012.1994.tb00263.x","article-title":"Acute rejection episodes \u2013 best predictor of long\u2010term primary cadaveric renal transplant survival","volume":"8","author":"Ferguson","year":"1994","journal-title":"Clin Transplant"},{"issue":"3","key":"10.1034\/j.1600-6143.2002.20612.x_bib2","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/00007890-199508000-00003","article-title":"Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. U.S. Renal Transplant Mycophenolate Mofetil Study Group","volume":"60","author":"Sollinger","year":"1995","journal-title":"Transplantation"},{"issue":"11","key":"10.1034\/j.1600-6143.2002.20612.x_bib3","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1097\/00007890-199606150-00005","article-title":"One\u2010year follow\u2010up of an open\u2010label trial of FK506 for primary kidney transplantation. A report of the U.S. Multicenter FK506 Kidney Transplant Group","volume":"61","author":"Vincenti","year":"1996","journal-title":"Transplantation"},{"key":"10.1034\/j.1600-6143.2002.20612.x_bib4","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1399-0012.1991.tb00147.x","article-title":"Immunosuppression in renal transplantation. II. Corticosteroids, antilymphocyte globulin, and OKT3","volume":"5","author":"Gruber","year":"1991","journal-title":"Clin Transplant"},{"key":"10.1034\/j.1600-6143.2002.20612.x_bib5","first-page":"S26","article-title":"Mechanisms of action of new immunosuppressive drugs","volume":"53","author":"Morris","year":"1996","journal-title":"Kidney Int Suppl"},{"issue":"8546","key":"10.1034\/j.1600-6143.2002.20612.x_bib6","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0140-6736(87)90648-9","article-title":"Prevention of rejection of kidney transplants by monoclonal antibody directed against interleukin","volume":"1","author":"Soulillou","year":"1987","journal-title":"Lancet"},{"issue":"1","key":"10.1034\/j.1600-6143.2002.20612.x_bib7","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/00007890-198901000-00013","article-title":"Prolongation of primate renal allograft survival by anti\u2010Tac, an anti\u2010human IL\u20102 receptor monoclonal antibody","volume":"47","author":"Reed","year":"1989","journal-title":"Transplantation"},{"issue":"6","key":"10.1034\/j.1600-6143.2002.20612.x_bib8","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1097\/00007890-198812000-00001","article-title":"Interleukin 2 receptor\u2010targeted therapy \u2013 rationale and applications in organ transplantation","volume":"46","author":"Kupeic\u2010Weglinski","year":"1988","journal-title":"Transplantation"},{"issue":"1","key":"10.1034\/j.1600-6143.2002.20612.x_bib9","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1432-2277.1989.tb01837.x","article-title":"Monoclonal anti\u2010IL2\u2010receptor in organ transplantation","volume":"2","author":"Soulillou","year":"1989","journal-title":"Transpl Int"},{"issue":"5 Suppl. 2","key":"10.1034\/j.1600-6143.2002.20612.x_bib10","first-page":"54","article-title":"Prophylactic use of monoclonal anti\u2010IL\u20102 receptor antibody in cadaveric renal transplantation","volume":"14","author":"Carpenter","year":"1989","journal-title":"Am J Kidney Dis"},{"key":"10.1034\/j.1600-6143.2002.20612.x_bib11","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/00007890-199101000-00016","article-title":"A randomized prospective trial of anti\u2010Tac monoclonal antibody in human renal transplantation","volume":"51","author":"Kirkman","year":"1991","journal-title":"Transplantation"},{"issue":"3","key":"10.1034\/j.1600-6143.2002.20612.x_bib12","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/00007890-199508000-00007","article-title":"A double\u2010blind, placebo\u2010controlled study of monoclonal anti\u2010interleukin\u20102 receptor antibody (BT563) administration to prevent acute rejection after kidney transplantation","volume":"60","author":"Van Gelder","year":"1995","journal-title":"Transplantation"},{"key":"10.1034\/j.1600-6143.2002.20612.x_bib13","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1097\/00007890-199510150-00023","article-title":"Protein structure prolonged action of a chimeric interleukin\u20102 receptor (CD25) monoclonal antibody used in cadaveric renal transplantation","volume":"60","author":"Amlot","year":"1995","journal-title":"Transplantation"},{"key":"10.1034\/j.1600-6143.2002.20612.x_bib14","first-page":"385","article-title":"Pharmacokinetics and pharmacodynamic studies of one or two doses of daclizumab in renal transplant patient. [Abstract]","volume":"1","author":"Vincenti","year":"2001","journal-title":"Am J Transplant"},{"issue":"9086","key":"10.1034\/j.1600-6143.2002.20612.x_bib15","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/S0140-6736(97)09278-7","article-title":"Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients. CHIB 201 International Study Group","volume":"350","author":"Nashan","year":"1997","journal-title":"Lancet"},{"issue":"3","key":"10.1034\/j.1600-6143.2002.20612.x_bib16","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1056\/NEJM199801153380304","article-title":"Interleukin\u20102\u2010receptor blockade with daclizumab to prevent acute rejection in renal transplantation. Daclizumab Triple Therapy Study Group","volume":"338","author":"Vincenti","year":"1998","journal-title":"N Engl J Med"},{"issue":"67","key":"10.1034\/j.1600-6143.2002.20612.x_bib17","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/00007890-199901270-00016","article-title":"Reduction of the occurrence of acute cellular rejection among renal allograft recipients treated with basiliximab, a chimeric anti\u2010interleukin\u20102\u2010receptor monoclonal antibody. United States Simulect Renal Study Group.","volume":"27","author":"Kahan","year":"1999","journal-title":"Transplantation"},{"issue":"7","key":"10.1034\/j.1600-6143.2002.20612.x_bib18","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1097\/00007890-199704150-00013","article-title":"A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group","volume":"63","author":"Pirsch","year":"1997","journal-title":"Transplantation"},{"issue":"2","key":"10.1034\/j.1600-6143.2002.20612.x_bib19","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/00007890-200101270-00019","article-title":"A worldwide, phase III, randomized, controlled, safety and efficacy study of a sirolimus\/cyclosporine regimen for prevention of acute rejection in recipients of primary mismatched renal allografts","volume":"71","author":"MacDonald","year":"2001","journal-title":"Transplantation"},{"issue":"5","key":"10.1034\/j.1600-6143.2002.20612.x_bib20","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1097\/00007890-200003150-00028","article-title":"Randomized trial of tacrolimus (Prograf) in combination with azathioprine or mycophenolate mofetil versus cyclosporine (Neoral) with mycophenolate mofetil after cadaveric kidney transplantation","volume":"69","author":"Johnson","year":"2000","journal-title":"Transplantation"},{"issue":"1\u20132","key":"10.1034\/j.1600-6143.2002.20612.x_bib21","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/S0041-1345(98)01929-0","article-title":"Tacrolimus\/\u2032low\u2010dose\u2032 mycophenolate mofetil versus microemulsion cyclosporine\/\u2032low\u2010dose\u2032 mycophenolate mofetil after kidney transplantation \u2013 1\u2010year follow\u2010up of a prospective, randomized clinical trial","volume":"31","author":"Yang","year":"1999","journal-title":"Transplant Proc"},{"issue":"4","key":"10.1034\/j.1600-6143.2002.20612.x_bib22","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/S0041-1345(98)00283-8","article-title":"Oral ganciclovir in the prevention of cytomegalovirus infection in postkidney transplant \u2018CMV at risk\u2019 recipients: a controlled, comparative study of two regimens (750 mg Bid and 500 mg Bid)","volume":"30","author":"Ahsan","year":"1998","journal-title":"Transplant Proc"},{"issue":"2","key":"10.1034\/j.1600-6143.2002.20612.x_bib23","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1046\/j.1523-1755.1999.00299.x","article-title":"The Banff 97 working classification of renal allograft pathology","volume":"55","author":"Racusen","year":"1999","journal-title":"Kidney Int"},{"issue":"2","key":"10.1034\/j.1600-6143.2002.20612.x_bib24","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/00007890-199202010-00013","article-title":"The incidence and impact of early rejection episodes on graft outcome in recipients of first cadaver kidney transplants","volume":"53","author":"Gulanikar","year":"1992","journal-title":"Transplantation"},{"issue":"2","key":"10.1034\/j.1600-6143.2002.20612.x_bib25","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/00007890-199308000-00010","article-title":"The impact of acute rejection episodes on long\u2010term graft function and outcome in 1347 primary renal transplants treated by 3 cyclosporine regimens","volume":"56","author":"Lindholm","year":"1993","journal-title":"Transplantation"},{"issue":"4","key":"10.1034\/j.1600-6143.2002.20612.x_bib26","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/j.1399-0012.1995.tb00337.x","article-title":"An analysis of predictors of long\u2010term cadaveric renal allograft survival","volume":"9","author":"Cole","year":"1995","journal-title":"Clin Transplant"},{"issue":"2","key":"10.1034\/j.1600-6143.2002.20612.x_bib27","first-page":"913","article-title":"Prolonged immunosuppressive effect and minimal immunogenicity from chimeric (CD25) monoclonal antibody SDZ CHI 621 in renal transplantation","volume":"28","author":"Kovarik","year":"1996","journal-title":"Transplant Proc"},{"issue":"2","key":"10.1034\/j.1600-6143.2002.20612.x_bib28","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/00007890-200107270-00014","article-title":"Randomized trial of Prograf + mycophenolate mofetil or azathioprine versus neoral with mycophenolate mofetil after cadaveric kidney transplantation. Results at two years","volume":"72","author":"Ahsan","year":"2001","journal-title":"Transplantation"},{"issue":"7","key":"10.1034\/j.1600-6143.2002.20612.x_bib29","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/00007890-199904150-00957","article-title":"Single dose intra\u2010operative OKT\u20103 induction, a novel approach to reduce acute rejection in kidney transplant recipients \u2013 1\u2010year follow\u2010up of a single center prospective study. [Abstract]","volume":"67","author":"Ahsan","year":"1999","journal-title":"Transplantation"},{"issue":"2 Suppl. 2","key":"10.1034\/j.1600-6143.2002.20612.x_bib30","first-page":"207","article-title":"Cyclosporine potentiates the immunosuppressive effects of anti\u2010interleukin 2 receptor monoclonal antibody therapy","volume":"20","author":"Kupiec\u2010Weglinski","year":"1988","journal-title":"Transplant Proc"},{"issue":"2","key":"10.1034\/j.1600-6143.2002.20612.x_bib31","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1034\/j.1399-0012.2001.150208.x","article-title":"Differential influence of azathioprine and mycophenolate mofetil on the disposition of basiliximab in renal transplant patients.","volume":"15","author":"Kovarik","year":"2001","journal-title":"Clin Transplant"},{"issue":"12","key":"10.1034\/j.1600-6143.2002.20612.x_bib32","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1097\/00007890-199712270-00012","article-title":"Disposition of basiliximab, an interleukin\u20102 receptor monoclonal antibody, in recipients of mismatched cadaver renal allografts","volume":"64","author":"Kovarik","year":"1997","journal-title":"Transplantation"}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1034%2Fj.1600-6143.2002.20612.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1034%2Fj.1600-6143.2002.20612.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522070873?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522070873?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1034\/j.1600-6143.2002.20612.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T04:26:20Z","timestamp":1761625580000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613522070873"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,6]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2002,6]]}},"alternative-id":["S1600613522070873"],"URL":"https:\/\/doi.org\/10.1034\/j.1600-6143.2002.20612.x","relation":{},"ISSN":["1600-6135"],"issn-type":[{"type":"print","value":"1600-6135"}],"subject":[],"published":{"date-parts":[[2002,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Limited Dose Monoclonal IL\u20102R Antibody Induction Protocol after Primary Kidney Transplantation","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1034\/j.1600-6143.2002.20612.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2002 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}